IMV Inc. — Form D
IMV Inc. of DARTMOUTH, A5, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-03. The offering totals $750K. Industry: Biotechnology.
Offering
- Filed: 2022-01-03
- Form: D
- Accession: 0001734768-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $750K
- Remaining: $750K
- Investors: 2
- Date of first sale: 2021-12-17
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-427645
Issuer
- Name: IMV Inc.
- CIK: 0001734768
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Address: 130 EILEEN STUBBS AVE., DARTMOUTH, A5, B3B 2C4
- Phone: 9024921819
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Michael Bailey | Director | Emerald Hills, CA |
| Julia Gregory | Director | South San Francisco, CA |
| Michael Kalos | Director | Glencoe, IL |
| Kyle Kuvalanka | Director | Dartmouth, A5 |
| Andrew Sheldon | Director | Dartmouth, A5 |
| Shermaine Tilley | Director | Vancouver, A1 |
| Markus Warmuth | Director | c/o Ventus Therapeutics U.S.,, MA |
| Jeremy Graff | Executive Officer | Dartmouth, A5 |
| Andrew Hall | Executive Officer | Chicago, IL |
| Pierre Labbe | Executive Officer | Dartmouth, A5 |
| James P Hall | Director | Dartmouth, A5 |
| Julia P Gregory | Director | Dartmouth, A5 |
| Wayne P Pisano | Director | Dartmouth, A5 |
| Markus P Warmuth | Director | Dartmouth, A5 |
| Frederic Ors | Director | Dartmouth, A5 |
| Frederic Ors | Executive Officer | Dartmouth, A5 |
| Shermaine P Tilley | Director | Dartmouth, A5 |
Other filings by this issuer (1)
More